Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobeline in Adult ADHD
NCT00664703Phase 2Completed
- Sponsor
- Ceptaris Therapeutics
- Start
- Jul 2008
- Primary completion
- Jan 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of lobeline in attention deficit hyperactivity disorder (ADHD), sponsored by Ceptaris Therapeutics. Started Jul 2008; status: completed.
02
Drugs
lobeline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00664703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664703.